Hematopoietic Support Capacity of Mesenchymal Stem Cells: Biology and Clinical Potential

Archives of Medical Research

Volumn 46, Issue 8, 2015, Pages 589-596

  Fajardo Orduña, Guadalupe R ^a   Mayani, Héctor ^a   Montesinos, Juan J ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FUNCTION; CELL ISOLATION; CELL SUBPOPULATION; CELL THERAPY; EX VIVO STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; REVIEW; STEM CELL EXPANSION; ANIMAL; BIOLOGICAL THERAPY; BONE MARROW; BONE MARROW CELL; CELL PROLIFERATION; CYTOLOGY; MESENCHYMAL STROMA CELL; MOUSE; PHYSIOLOGY; PROCEDURES; RHESUS MONKEY;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MACACA MULATTA; MESENCHYMAL STROMAL CELLS; MICE;

EID: 84957378019     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2015.10.001     Document Type: Review

References (68)

1. Horwitz E.M., Le Blanc K., Dominici M., et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy Position Statement. Cytotherapy 2005, 7:393-395.
2. Friedenstein A.J., Chailakhyan R.K., Latsinik N.V., et al. Stromal cells responsible for transferring the microenvironment of the hematopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974, 17:331-340.
3. Bernardo M.E., Cometa A.M., Locatelli F. Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation?. Bone Marrow Transplant 2012, 47:323-329.
4. Ehninger A., Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 2011, 208:421-428.
5. Mayani H., Guilbert L.J., Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol 1992, 49:225-233.
6. Flores-Guzmán P., Fernández-Sánchez V., Mayani H. Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine. Stem Cells Transl Med 2013, 2:830-838.
7. He N., Zhang L., Cui J., et al. Bone marrow vascular niche: home for hematopoietic stem cells. Bone Marrow Res 2014, 2014:128436.
8. Wilson A., Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006, 6:93-106.
9. Sugiyama T., Kohara H., Noda M., et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
10. Nagasawa T., Omatsu Y., Sugiyama T. Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells. Trends Immunol 2011, 32:315-320.
11. Méndez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
12. Sacchetti B., Funari A., Michienzi S., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
13. Tormin A., Li O., Brune J.C., et al. CD146 expression on primary non-hematopoietic bone marrow stem cells is correlated with in situ localization. Blood 2011, 117:5067-5077.
14. Flores-Figueroa E., Varma S., Montgomery K., et al. Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow. Lab Invest 2012, 92:1330-1341.
15. + cells: a comparison with human bone marrow-derived mesenchymal stem cells. Tissue Cell 2013, 45:32-38.
16. Schajnovitz A., Itkin T., D'Uva G., et al. CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions. Nat Immunol 2011, 12:391-398.
17. Wagner W., Roderburg C., Wein F., et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 2007, 10:2638-2647.
18. Jang Y.K., Jung D.H., Jung M.H. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 2006, 85:212-225.
19. de Graaf C.A., Metcalf D. Thrombopoietin and hematopoietic stem cells. Cell Cycle 2011, 10:1582-1589.
20. Li T., Wu Y. Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche. Bone Marrow Res 2011, 2011:353878.
21. Zhang Y., Li C., Jiang X., et al. Human placenta-derived mesenchymal progenitor cells support culture expansion of long term culture-initiating cells from cord blood CD34+ cells. Exp Hematol 2004, 32:657-664.
22. Kimura Y., Ding B., Imai N., et al. c-Kit-mediated functional positioning of stem cells to their niches is essential for maintenance and regeneration of adult hematopoiesis. PLoS One 2011, 6:e26918.
23. Mayani H., Flores-Figueroa E., Pelayo R., et al. Hematopoyesis. Cancerología 2007, 2:95-107.
24. de Kruijf E.J., Hagoort H., Velders G.A., et al. Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration. Haematologica 2010, 95:1061-1067.
25. Barreda D.R., Hanington P.C., Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 2004, 28:509-554.
26. Flores-Figueroa E., Montesinos J.J., Mayani H. Células troncales mesenquimales: historia, biología y aplicación clínica. Rev Invest Clin 2006, 58:498-511.
27. Wein F., Pietsch L., Saffrich R., et al. N-Cadherin is expressed on human hematopoietic progenitor cells and mediates interaction with human mesenchymal stromal cells. Stem Cell Res 2010, 4:129-139.
28. Simmons P.J., Masinovsky B., Longenecker B.M., et al. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992, 80:388-395.
29. Majumdar M.K., Keane-Moore M., Buyaner D., et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 2003, 10:228-241.
30. Prosper F., Verfaillie C.M. Regulation of hematopoiesis through adhesion receptors. J Leukoc Biol 2001, 69:307-316.
31. Montesinos J.J., Flores-Figueroa E., Castillo-Medina S., et al. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy 2009, 11:163-176.
32. Chitteti B.R., Cheng Y.H., Kacena M.A., et al. Hierarchical organization of osteoblasts reveals the significant role of CD166 in hematopoietic stem cell maintenance and function. Bone 2013, 54:58-67.
33. Pilz G.A., Ulrich C., Ruh M., et al. Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells. Stem Cells Dev 2011, 20:635-646.
34. Zuckerman K.S., Rhodes R.K., Goodrum D.D., et al. Inhibition of collagen deposition in the extracellular matrix prevents the establishment of a stroma supportive of hematopoiesis in long-term murine bone marrow cultures. J Clin Invest 1985, 75:970-975.
35. Hurley R.W., McCarthy J.B., Verfaillie C.M. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 1995, 96:511-519.
36. Sittichokechaiwut A., Edwards J.H., Scutt A.M., et al. Short bouts of mechanical loading are as effective as dexamethasone at inducing matrix production by human bone marrow mesenchymal stem cell. Eur Cell Mater 2010, 20:45-57.
37. Nilsson S.K., Johnston H.M., Whitty G.A., et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005, 106:1232-1239.
38. Fujita S., Toguchida J., Morita Y., et al. Clonal analysis of hematopoiesis-support activity of human mesenchymal stem cells in association with jagged 1 expression and osteogenic potential. Cell Transplant 2008, 17:1169-1179.
39. Delalat B., Pourfathollah A.A., Soleimani M., et al. Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells. Hematology 2009, 14:125-132.
40. Angelopoulou M., Novelli E., Grove J.E., et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 2003, 31:413-420.
41. Kim D.H., Yoo K.H., Yim Y.S., et al. Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice. J Korean Med Sci 2006, 21:1000-1004.
42. Kim D.W., Chung Y.J., Kim T.G., et al. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004, 103:1941-1948.
43. Muguruma Y., Yahata T., Miyatake H., et al. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 2006, 107:1878-1887.
44. Almeida-Porada G., Porada C.D., Tran N., et al. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000, 95:3620-3627.
45. Liu L.H., Sun Q.Y., Hu K.X., et al. Establishment of a rhesus haploidentical hematopoietic stem cell and mesenchymal stem cell transplantation model by nonmyeloablative conditioning. Zhonghua Xue Ye Xue Za Zhi 2005, 26:385-388.
46. Flores-Guzmán P., Flores-Figueroa E., Montesinos J.J., et al. Individual and combined effects of mesenchymal stromal cells and recombinant stimulatory cytokines on the in vitro growth of primitive hematopoietic cells from human umbilical cord blood. Cytotherapy 2009, 11:886-896.
47. de Lima M., McNiece I., Robinson S.N., et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med 2012, 367:2305-2315.
48. Available at: Accessed 2 September 2015. http://clinicaltrials.gov/.
49. Kim E.J., Kim N., Cho S.G. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Exp Mol Med 2013, 45:e2.
50. Wu K.H., Tsai C., Wu H.P., et al. Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation. Cell Transplant 2013, 22:2041-2051.
51. Wu K.H., Wu H.P., Chan C.K., et al. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides. Cell Transplant 2013, 22:723-729.
52. Ball L.M., Bernardo M.E., Roelofs H., et al. Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007, 110:2764-2767.
53. Koç O.N., Gerson S.L., Cooper B.W., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000, 18:307-316.
54. Le Blanc K., Samuelsson H., Gustafsson B., et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007, 21:1733-1738.
55. Meuleman N., Tondreau T., Ahmad I., et al. Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. Stem Cells Dev 2009, 18:1247-1252.
56. Macmillan M.L., Blazar B.R., DeFor T.E., et al. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant 2009, 43:447-454.
57. Gonzalo-Daganzo R., Regidor C., Martín-Donaire T., et al. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 2009, 11:278-288.
58. Bernardo M.E., Ball L.M., Cometa A.M., et al. Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant 2011, 46:200-207.
59. Fekete N., Rojewski M.T., Fürst D., et al. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS One 2012, 7:e43255.
60. Bara J.J., Richards R.G., Alini M., et al. Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: Implications for basic research and the clinic. Stem Cells 2014, 32:1713-1723.
61. Galotto M., Berisso G., Delfino L., et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 1999, 27:1460-1466.
62. Hou R.Q., Wang J., Kong Y., et al. Transfusion of mesenchymal stem cells combined with haploidentical HSCT improves hematopoietic microenvironment. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010, 18:155-160.
63. Wang J., Huang X.J., Xu L.P., et al. Monitoring the source of mesenchymal stem cells in patients after transplantation of mismatched-sex hematopoietic stem cells plus third-party cells. Chin Med J (Engl) 2013, 126:4254-4259.
64. Ullah I., Baregundi Subbarao R., Rho G.J. Human mesenchymal stem cells- current trends and future prospective. Biosci Rep 2015, 35.
65. Wang H., Yan H., Wang Z., et al. Cotransplantation of allogeneic mesenchymal and hematopoietic stem cells in children with aplastic anemia. Pediatrics 2012, 129:e1612-e1615.
66. Hiwase S.D., Dyson P.G., To L.B., et al. Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engrafment in nonobese diabetic/severe combined immune deficient mice. Stem Cells 2009, 27:2293-2300.
67. Yim Y.S., Noh Y.H., Kim D.H., et al. Correlation between the immature characteristics of umbilical cord blood-derived mesenchymal stem cells and engraftment of hematopoietic stem cells in NOD/SCID mice. Transplant Proc 2010, 42:2753-2758.
68. Li X.H., Gao C.J., Da W.M., et al. Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia. PLoS One 2014, 9:e89666.